TrialHaemophilia : the official journal of the World Federation of Hemophilia2025

A phase 1/2 safety and efficacy study of TAK-754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials.

John Chapin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.